Skip the main content if you do not want to read it as the next section.
Skip the location trail if you do not want to read it as the next section.
Location trail
HEALTH PROFESSIONALS > TREATMENT GUIDELINES > SPECIFIC CANCERS > MYELOMAUK Treatment Guidelines - Myeloma
- Guidelines on the diagnosis and management of multiple myeloma - 2005
- Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma - UKMF, 2004
- Thalidomide in multiple myeloma: Current status and future prospects - BSH - 2003
- Guidelines on the diagnosis and management of multiple myeloma – UK Myeloma Forum – 2001
- Guidelines on the provision of facilities for the care of adult patients with haematological malignancies. (including leukaemia, lymphoma and severe bone marrow failure.) – BCSH - 1995
Guidelines on the diagnosis and management of multiple myeloma - 2005
Produced by: Guidelines Working Group of the UK Myeloma Forum (UKMF) and the Nordic Myeloma Study Group (NMSG).
Purpose: Latest guidance on the diagnosis and management of multiple myeloma including new sections on imaging and the management of skeletal disease, developments in disease classification and new therapeutic approaches such as thalidomide, bortezomib and reduced intensity allogeneic transplantation.
Can be obtained from: These guidelines are available electronically from the British Committee for Standards in Haematology (BCSH) website.
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma - UKMF, 2004
Produced by: UK Myeloma Forum on behalf of the British Committee for Standards in Haematology (BCSH), 2004.
Purpose: To set out the key areas of strategy in the effective clinical management of myeloma.
Can be obtained from: http://www.ukmf.org.uk/ or British Journal of Haematology 124, 2004, pp717-726 or The British Society for Haematology, 100 White Lion Street, London N1 9PF Tel: 020 8643 7305
Thalidomide in multiple myeloma: Current status and future prospects - BSH - 2003
Produced by: British Committee for Standards in Haematology (BCSH), a sub-committee of the British Society for Haematology (BSH), 2003
Purpose: To provide haematologists with up to date advice on the diagnosis and treatment of haematological disease by the production of evidence based guidelines.
Can be obtained from: British Journal of Haematology 2003, v120, p18-26 or The British Society for Haematology, 100 White Lion Street, London N1 9PF Tel: 020 8643 7305
Guidelines on the diagnosis and management of multiple myeloma – UK Myeloma Forum – 2001
Produced by: UK Myeloma Forum on behalf of the British Committee for Standards in Haematology (BCSH), 2001.
Purpose: To set out the key areas of strategy in the effective clinical management of myeloma.
Can be obtained from: www.ukmf.org.uk/ or British Journal of Haematology 115, 2001, pp522-40 or The British Society for Haematology, 100 White Lion Street, London N1 9PF Tel: 020 8643 7305
Guidelines on the provision of facilities for the care of adult patients with haematological malignancies. (including leukaemia, lymphoma and severe bone marrow failure.) – BCSH - 1995
Produced by: The British Committee for Standards in Haematology (BCSH) is a sub-committee of the British Society for Haematology (BSH).
Purpose: To provide haematologists with up to date advice on the diagnosis and treatment of haematological disease by the production of evidence based guidelines.
Can be obtained from: Clinical and Laboratory Haematology 1995; v17, p3-10 or The British Society for Haematology, 100 White Lion Street, London N1 9PF Tel: 020 8643 7305
Content last reviewed: 20 October 2005
Page last modified: 02 May 2007
Page last modified: 02 May 2007